Literature DB >> 12488456

The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene.

Tamara Nowling1, Cory Bernadt, Lance Johnson, Michelle Desler, Angie Rizzino.   

Abstract

Distal enhancers commonly regulate gene expression. However, the mechanisms of transcriptional mediation by distal enhancers remain largely unknown. To better understand distal enhancer-mediated transcription, we examined the regulation of the FGF-4 gene. The FGF-4 gene is regulated during early development by a powerful distal enhancer located downstream of the promoter in exon 3. Sox-2 and Oct-3 bind to the enhancer and are required for the activation of the FGF-4 gene. Previously, we implicated the co-activator p300 as a mediator of Sox-2/Oct-3 synergistic activation of a heterologous promoter, suggesting that p300 may play a role in mediating enhancer activation of the FGF-4 gene. In this study, we provide both functional and physical evidence that p300 plays an important role in the action of the FGF-4 enhancer. Specifically, we show that E1a, but not a mutant form of E1a that is unable to bind p300, inhibits enhancer activation of the FGF-4 promoter. We also demonstrate that Gal4/p300 fusion proteins can stimulate the FGF-4 promoter when bound to the FGF-4 enhancer. Additionally, we present evidence that p300 mediation of the FGF-4 enhancer requires acetyltransferase activity. Importantly, we also show that Sox-2 and p300 are physically associated with the endogenous FGF-4 enhancer but weakly associated with the endogenous FGF-4 promoter. These results are consistent with a model of transitory interaction between the distal enhancer and the FGF-4 promoter. Our results also suggest that intragenic distal enhancers may use mechanisms that differ from extragenic distal enhancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12488456     DOI: 10.1074/jbc.M207567200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

2.  Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells.

Authors:  Jesse L Cox; Sunil K Mallanna; Briana D Ormsbee; Michelle Desler; Matthew S Wiebe; Angie Rizzino
Journal:  J Cell Sci       Date:  2011-07-12       Impact factor: 5.285

3.  Regulation of the Nanog gene by both positive and negative cis-regulatory elements in embryonal carcinoma cells and embryonic stem cells.

Authors:  Brian Boer; Jesse L Cox; David Claassen; Sunil Kumar Mallanna; Michelle Desler; Angie Rizzino
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

Review 4.  Role of SoxB1 transcription factors in development.

Authors:  Satoru Miyagi; Hidemasa Kato; Akihiko Okuda
Journal:  Cell Mol Life Sci       Date:  2009-07-25       Impact factor: 9.261

5.  Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

Authors:  Bo Ram Kim; Etienne Coyaud; Estelle M N Laurent; Jonathan St-Germain; Emily Van de Laar; Ming-Sound Tsao; Brian Raught; Nadeem Moghal
Journal:  Mol Cell Proteomics       Date:  2017-08-09       Impact factor: 5.911

Review 6.  Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells.

Authors:  Angie Rizzino
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Sep-Oct

7.  An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs.

Authors:  Heidi G Parker; Bridgett M VonHoldt; Pascale Quignon; Elliott H Margulies; Stephanie Shao; Dana S Mosher; Tyrone C Spady; Abdel Elkahloun; Michele Cargill; Paul G Jones; Cheryl L Maslen; Gregory M Acland; Nathan B Sutter; Keiichi Kuroki; Carlos D Bustamante; Robert K Wayne; Elaine A Ostrander
Journal:  Science       Date:  2009-07-16       Impact factor: 47.728

Review 8.  Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors.

Authors:  Véronique Lefebvre; Bogdan Dumitriu; Alfredo Penzo-Méndez; Yu Han; Bhattaram Pallavi
Journal:  Int J Biochem Cell Biol       Date:  2007-06-06       Impact factor: 5.085

9.  The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7.

Authors:  Tanmayi P Mankame; Mark W Lingen
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

10.  SRY-box-containing gene 2 regulation of nuclear receptor tailless (Tlx) transcription in adult neural stem cells.

Authors:  Koji Shimozaki; Chun-Li Zhang; Hoonkyo Suh; Ahmet M Denli; Ronald M Evans; Fred H Gage
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.